唾液採集與診斷市場－全球產業規模、佔有率、趨勢、機會及預測（依採集地點、應用、最終用戶、地區及競爭格局分類，2021-2031年）

全球唾液採集和診斷市場預計將從 2025 年的 8.2218 億美元成長到 2031 年的 11.0874 億美元，複合年成長率為 5.11%。

此細分市場涵蓋用於非侵入性採集和分析口腔生物體液以檢測遺傳標記、傳染性病原體和一般健康指標的技術。推動該市場發展的關鍵因素是患者越來越傾向於選擇無痛檢測方式，以取代靜脈抽血和鼻咽拭子，這種轉變顯著提高了檢測依從性，尤其是在兒童和老年人群體中。此外，醫療保健分散化的趨勢也促進了穩定型唾液採集試劑盒的使用。這些試劑盒可在室溫下安全運輸，方便在偏遠地區進行檢測和分子診斷。

儘管唾液診斷具有巨大潛力，但該行業在法規核准和生物標記檢驗方面仍面臨許多挑戰，尤其是在與既定血液標準進行比對方面。製造商難以證明檢體均一性和診斷等效性，而這些正是獲得上市前核准所必需的。美國牙科協會 (ADA) 強調了這項挑戰的嚴峻性。 ADA 指出，截至 2024 年 10 月，將沒有獲得 FDA已通過核准的市售唾液診斷測試可用於評估牙周病、齲齒或頭頸癌的風險，這凸顯了目前存在的嚴格檢驗障礙。

市場促進因素

由於診斷方法的去中心化和患者自我管理能力的提高，照護現場（POC​​）和居家檢測的普及是市場擴張的關鍵促進因素。這種發展趨勢使得人們無需前往醫療機構即可自行檢體進行感染疾病和一般健康狀況的檢測，從而有效避免了諸如後勤挑戰和與檢測相關的社會污名等障礙。監管機構正日益支持這些以患者為中心的模式，以擴大公共衛生覆蓋範圍並促進弱勢群體早期發現疾病。例如，美國食品藥物管理局（FDA）於2024年12月核准了OraQuick HIV自檢檢測套組，將其適用年齡下調至14至17歲的青少年。這標誌著檢測工具正朝著更容易獲取、更商業化的方向發展，旨在賦能年輕一代積極參與自身健康管理。

同時，唾液體學和生物標記發現領域的技術進步正大大拓展口腔液的效用，使其遠遠超越基本的病毒檢測和藥物篩檢。研究人員正積極驗證用於系統性疾病的新型檢驗，從而推動對多標靶平台的投資，這些平台可提供與血液檢測相當的臨床準確性。這項科學研究勢頭得到了政府的大力支持，美國國家牙科和顱顏研究所 (NIDCR) 在 2024 會計年度投資超過 300 萬美元用於唾液診斷研究，以加速快速檢測設備的開發。此類資金正在推動創新，例如頻譜 Solutions 公司於 2024 年 3 月推出的「SimplyPERIO」唾液檢測。此檢測可從單一檢體中識別 16 種口腔靶點，標誌著早期療育正朝著高通量分子分析的方向發展。

市場挑戰

全球唾液採集和診斷市場面臨許多限制因素，包括嚴格的監管要求和複雜的臨床檢驗（需證明其與血液檢測標準等效）。製造商面臨著很高的進入門檻，必須證明唾液衍生的生物標記與已建立的血漿和血清檢測方法具有相同的診斷準確性和可靠性。這些嚴格的生物等效性需求導致研發週期長且成本高昂，迫使企業在商業化之前投入大規模資金進行對照研究。因此，核准流程的不確定性抑制了投資，並減緩了創新非侵入性檢測技術的應用。

這些監管壁壘直接減少了可用檢測項目的種類，並限制了患者獲得先進診斷設備的機會。面對不斷變化的合規標準和更高的證據要件，實驗室往往選擇減少檢測項目，而不是耗費巨資核准程序。這種市場萎縮趨勢反映在近期的產業調查結果中。根據2024年診斷和實驗室醫學協會（ADLM）的調查數據，超過50%的實驗室表示，由於無法滿足新的、更嚴格的監管標準，他們計劃停止提供某些實驗室自研檢測項目。這表明，監管摩擦不僅阻礙了新進入者，也排除了現有解決方案，最終減緩了整個產業的發展。

市場趨勢

基於唾液的液態生物檢體技術的進步正拓展至預防腫瘤學領域，使得以往需要侵入性檢查才能發現的全身性癌症能夠以非侵入性方式進行識別。此方法利用唾液微生物組和RNA數據來檢測特定的腫瘤標記和癌前指標，顯著擴展了口腔液的應用範圍，使其不再局限於局部疾病的診斷。為了支持這項進展，News-Medical.Net於2025年7月報道，Viome Life Sciences已與斯克里普斯研究所達成策略合作，將開展一項包含1000名參與者的臨床試驗，旨在開發一種用於早期結直腸癌預防的基於唾液的RNA檢測方法。這項進展證實了口腔液是評估消化系統健康的可行介質，並有望減少對傳統大腸鏡檢查的依賴，從而為初步篩檢提供更多選擇。

同時，唾液檢測在藥物基因體學領域的快速發展，正透過簡化檢體採集流程，實現精準用藥管理，進而變革個人化醫療。越來越多的實驗室採用基於唾液的基因組檢測方案來研究患者的藥物代謝，這有助於在神經病學和精神病學等複雜領域中最大限度地減少藥物副作用。 Quest Diagnostics 於 2025 年 9 月推出了一項先進的藥物基因組學檢測服務，該服務可分析 17 個基因和 4 個 HLA 等位基因，為醫生的處方策略提供支持，這標誌著市場正朝著這一方向發展。這項進步表明，將基於唾液的基因資訊整合到臨床實踐中具有商業性實用化，從而能夠根據個體代謝特徵制定個人化治療方案。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球唾液採集與診斷市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依採集部位（腮腺採集、下頷腺/舌下腺採集、其他）
  • 按應用領域（疾病診斷、法醫學應用、調查）
  • 依最終用戶（牙醫、診斷檢查室、製藥和生技公司、研究機構）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美唾液採集與診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲唾液採集與診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區唾液採集與診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東與非洲唾液採集與診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲唾液採集與診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球唾液採集與診斷市場：SWOT分析

第14章 波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• DNA Genotek
• Salimetrics
• OraSure
• Qiagen
• Thermo Fisher
• Abbott
• Nipro
• Zymo Research
• LabCorp
• BioDiagnostics Companies

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Saliva Collection & Diagnostics Market is projected to expand from a valuation of USD 822.18 Million in 2025 to USD 1108.74 Million by 2031, registering a CAGR of 5.11%. This sector covers technologies dedicated to the non-invasive collection and analysis of oral biofluids to detect genetic markers, infectious agents, and general health indicators. A primary catalyst for this market is the growing patient preference for painless alternatives to venous blood draws and nasopharyngeal swabs, a shift that notably improves adherence among children and the elderly. Additionally, the push toward decentralized healthcare is promoting the use of stabilized saliva kits, which allow for safe ambient transport to support remote testing and molecular diagnostics.

Despite this potential, the industry encounters significant hurdles related to regulatory clearance and the validation of biomarkers against established blood standards. Manufacturers struggle to prove sample consistency and diagnostic equivalence required for premarket approval. The severity of this challenge is highlighted by the American Dental Association, which noted that as of October 2024, there were no commercially available, FDA-approved salivary diagnostic tests for evaluating risks associated with periodontal disease, dental caries, or head and neck cancer, demonstrating the strict barriers to validation that currently exist.

Market Driver

The proliferation of point-of-care (POC) and at-home testing sectors is a major force driving market expansion by decentralizing diagnostic availability and giving patients more control. This evolution enables individuals to conduct self-sampling for infectious diseases and general wellness without needing to visit clinical sites, effectively bypassing obstacles like logistical difficulties and the stigma often associated with testing. Regulatory authorities are increasingly endorsing these patient-focused models to extend public health coverage and facilitate early detection in vulnerable groups. For example, the U.S. Food and Drug Administration (FDA) approved a supplement for the OraQuick HIV Self-Test in December 2024, lowering the usage age to include adolescents aged 14 to 17, signaling a shift toward accessible over-the-counter tools that allow younger populations to manage their health proactively.

Simultaneously, technological progress in salivaomics and biomarker discovery is expanding the utility of oral fluids well beyond basic viral detection or drug screening. Researchers are actively validating new analytes for systemic diseases, prompting investments in multi-target platforms that achieve clinical-grade accuracy similar to blood tests. This scientific drive is bolstered by significant government support; the National Institute of Dental and Craniofacial Research (NIDCR) invested over $3 million in salivary diagnostic research during fiscal year 2024 to accelerate the creation of rapid detection devices. Such funding is fueling innovation, as seen with Spectrum Solutions, which launched the SimplyPERIO saliva test in March 2024 to identify 16 specific oral targets from one sample, marking a shift toward high-throughput, molecular analysis for early intervention.

Market Challenge

The Global Saliva Collection & Diagnostics Market faces substantial constraints due to strict regulatory mandates and the intricate clinical validation needed to prove equivalence with blood-based benchmarks. Manufacturers encounter high entry barriers, as they must demonstrate that biomarkers derived from saliva provide the same diagnostic precision and reliability as established plasma or serum tests. This rigorous requirement for bioequivalence often prolongs development schedules and escalates expenses, compelling companies to fund extensive comparative studies prior to commercialization. Consequently, the uncertainty surrounding authorization pathways dampens investment enthusiasm and postpones the introduction of non-invasive testing innovations.

These regulatory obstacles directly reduce the variety of available tests and restrict patient access to advanced diagnostic instruments. Confronted with evolving compliance standards and higher evidentiary requirements, laboratories frequently choose to cut their test offerings rather than managing the expensive approval procedures. This trend of market shrinkage is reflected in recent industry findings; according to survey data from the Association for Diagnostics and Laboratory Medicine in 2024, over 50% of testing facilities intended to stop offering specific laboratory-developed tests because they could not meet new, more stringent regulatory criteria. This demonstrates how regulatory friction not only impedes new market entrants but also eliminates existing solutions, thereby retarding overall industry progress.

Market Trends

The evolution of saliva-based liquid biopsy is reaching into the realm of preventative oncology, allowing for the non-invasive identification of systemic cancers that once necessitated invasive techniques. This approach leverages salivary microbiome and RNA data to detect specific tumor markers and precancerous indicators, significantly expanding the application of oral fluids beyond localized disease diagnosis. Validating this progression, News-Medical.Net reported in July 2025 that Viome Life Sciences formed a strategic alliance with Scripps Research to execute a clinical trial with 1,000 participants, aiming to create a saliva-based RNA test for early colorectal cancer prevention. This development confirms oral fluids as a feasible medium for evaluating gastrointestinal health, offering a potential reduction in the dependency on conventional colonoscopies for initial screenings.

In parallel, the growth of saliva testing within pharmacogenomics is transforming personalized medicine by enabling precise medication management through easier sample collection methods. Laboratories are increasingly adopting saliva-based genomic panels to examine how patients metabolize medications, helping to minimize adverse reactions in complex fields such as neurology and psychiatry. Highlighting this market shift, Quest Diagnostics introduced an advanced pharmacogenomic laboratory service in September 2025 capable of analyzing 17 genes and 4 HLA alleles to inform physician prescribing strategies. This advancement emphasizes the increasing commercial practicality of utilizing saliva to integrate genetic insights into standard clinical practices, ensuring that treatments are customized to individual metabolic profiles.

Key Market Players

• DNA Genotek
• Salimetrics
• OraSure
• Qiagen
• Thermo Fisher
• Abbott
• Nipro
• Zymo Research
• LabCorp
• BioDiagnostics Companies

Report Scope

In this report, the Global Saliva Collection & Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Saliva Collection & Diagnostics Market, By Site of Collection

• Parotid Gland Collection
• Submandibular/Sublingual Gland Collection
• Others

Saliva Collection & Diagnostics Market, By Application Type

• Disease Diagnostics
• Forensic Applications
• Research

Saliva Collection & Diagnostics Market, By End User

• Dentistry
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes

Saliva Collection & Diagnostics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Saliva Collection & Diagnostics Market.

Available Customizations:

Global Saliva Collection & Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Saliva Collection & Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Site of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection, Others)
  • 5.2.2. By Application Type (Disease Diagnostics, Forensic Applications, Research)
  • 5.2.3. By End User (Dentistry, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Saliva Collection & Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Site of Collection
  • 6.2.2. By Application Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Saliva Collection & Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Site of Collection
      • 6.3.1.2.2. By Application Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Saliva Collection & Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Site of Collection
      • 6.3.2.2.2. By Application Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Saliva Collection & Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Site of Collection
      • 6.3.3.2.2. By Application Type
      • 6.3.3.2.3. By End User

7. Europe Saliva Collection & Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Site of Collection
  • 7.2.2. By Application Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Saliva Collection & Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Site of Collection
      • 7.3.1.2.2. By Application Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Saliva Collection & Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Site of Collection
      • 7.3.2.2.2. By Application Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Saliva Collection & Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Site of Collection
      • 7.3.3.2.2. By Application Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Saliva Collection & Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Site of Collection
      • 7.3.4.2.2. By Application Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Saliva Collection & Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Site of Collection
      • 7.3.5.2.2. By Application Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Saliva Collection & Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Site of Collection
  • 8.2.2. By Application Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Saliva Collection & Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Site of Collection
      • 8.3.1.2.2. By Application Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Saliva Collection & Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Site of Collection
      • 8.3.2.2.2. By Application Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Saliva Collection & Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Site of Collection
      • 8.3.3.2.2. By Application Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Saliva Collection & Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Site of Collection
      • 8.3.4.2.2. By Application Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Saliva Collection & Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Site of Collection
      • 8.3.5.2.2. By Application Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Saliva Collection & Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Site of Collection
  • 9.2.2. By Application Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Saliva Collection & Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Site of Collection
      • 9.3.1.2.2. By Application Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Saliva Collection & Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Site of Collection
      • 9.3.2.2.2. By Application Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Saliva Collection & Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Site of Collection
      • 9.3.3.2.2. By Application Type
      • 9.3.3.2.3. By End User

10. South America Saliva Collection & Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Site of Collection
  • 10.2.2. By Application Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Saliva Collection & Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Site of Collection
      • 10.3.1.2.2. By Application Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Saliva Collection & Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Site of Collection
      • 10.3.2.2.2. By Application Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Saliva Collection & Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Site of Collection
      • 10.3.3.2.2. By Application Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Saliva Collection & Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. DNA Genotek
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Salimetrics
• 15.3. OraSure
• 15.4. Qiagen
• 15.5. Thermo Fisher
• 15.6. Abbott
• 15.7. Nipro
• 15.8. Zymo Research
• 15.9. LabCorp
• 15.10. BioDiagnostics Companies

16. Strategic Recommendations

17. About Us & Disclaimer